Last updated on November 2019

Study of Durvalumab + Tremelimumab Durvalumab and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy


Find a site near you

Start Over

Research Site

Ostrava, Czechia
1.29miles
  Connect »